A Phase III Study of Eque-cel in Subjects With Len-refractory RRMM (FUMANBA-03)
Clinical trial NCT06464991 · RECRUITING
Trial details
- NCT number
- NCT06464991
- Sponsor
- Nanjing IASO Biotechnology Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-27
- Primary completion
- 2027-08-01
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.